Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma
Latest Information Update: 26 Sep 2024
At a glance
- Drugs Durvalumab (Primary) ; Fluorouracil; Mitomycin
- Indications Anal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms RADIANCE
Most Recent Events
- 28 Nov 2023 Planned End Date changed from 30 Jun 2026 to 31 Mar 2027.
- 28 Nov 2023 Planned primary completion date changed from 31 Mar 2024 to 31 Dec 2026.
- 15 Sep 2023 Planned primary completion date changed from 31 Mar 2023 to 31 Mar 2024.